Authors:
RACE E
GILBERT SM
SHELDON JG
ROSE JSL
MOFFATT AR
SITBON G
DISSANAYEKE SR
CAMMACK N
DUNCAN IB
Citation: E. Race et al., CORRELATION OF RESPONSE TO TREATMENT AND HIV GENOTYPIC CHANGES DURINGPHASE-III TRIALS WITH SAQUINAVIR AND REVERSE-TRANSCRIPTASE INHIBITOR COMBINATION THERAPY, AIDS, 12(12), 1998, pp. 1465-1474
Authors:
TOMLINSON PW
CRAIG JC
MOFFATT AR
ROBERTS NA
SHELDON JG
WHITTAKER L
DUNCAN IB
Citation: Pw. Tomlinson et al., HIV-1 FROM PATIENTS IN A PHASE-II CLINICAL-TRIAL WITH THE PROTEINASE-INHIBITOR (PI) SAQUINAVIR (SQV) TAKEN IN COMBINATION WITH RT INHIBITORS (RTIS) EXHIBITS VERY LITTLE REDUCED SENSITIVITY TO OTHER PIS, AIDS, 10, 1996, pp. 12-12
Authors:
GILBERT SM
JUPP R
MOFFATT AR
SHELDON JG
RACE E
Citation: Sm. Gilbert et al., IN-VITRO SELECTION OF HIV-1 VARIANTS WITH REDUCED SENSITIVITY TO SAQUINAVIR AND RITONAVIR BY SUCCESSIVE SEQUENTIAL PASSAGE, AIDS, 10, 1996, pp. 14-14
Authors:
RACE E
GILBERT SM
SHELDON JG
MOFFAT AR
TOMLINSON PW
DUNCAN IB
Citation: E. Race et al., LOW OCCURRENCE OF REDUCED SENSITIVITY TO SAQUINAVIR IN ANTIVIRAL COMBINATION - RESULTS FROM A PHASE-III CLINICAL-TRIAL (NV-14256), AIDS, 10, 1996, pp. 15-15
Authors:
WHITTAKER L
SCHAPIRO JM
CRAIG JC
WINTERS MA
TOMLINSON PW
SHELDON JG
MOFFATT AR
JACOBSEN H
DUNCAN IB
GILBERT S
CRAWFORD S
MERIGAN TC
Citation: L. Whittaker et al., AN ASSESSMENT OF PHENOTYPIC AND GENOTYPIC CORESISTANCE TO INHIBITORS OF HIV PROTEINASE FOLLOWING THERAPY WITH HIGH-DOSE SAQUINAVIR, AIDS, 10, 1996, pp. 17-17
Authors:
SHELDON JG
WILLIAMS SP
FULTON AM
BRINDLE KM
Citation: Jg. Sheldon et al., P-31 NMR MAGNETIZATION-TRANSFER STUDY OF THE CONTROL OF ATP TURNOVER IN SACCHAROMYCES-CEREVISIAE, Proceedings of the National Academy of Sciences of the United Statesof America, 93(13), 1996, pp. 6399-6404